How Hiv Drugs Market Will Dominate In Coming Years? Key Players: ViiV Healthcare, Gilead Sciences, Merck Sharp & Dohme, Bristol-Myers Squibb Company, Janssen, Pharmaceuticals, Theratechnologies, Mylan Pharmaceuticals, Genentech, AbbVie, others
The global HIV drugs market is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled "HIV/AIDS Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast periodRequest a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hiv-aids-drugs-market-101115
Leading Players operating in the Hiv Drugs Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o ViiV Healthcare
o Gilead Sciences
o Merck Sharp & Dohme
o Bristol-Myers Squibb Company
o Janssen Pharmaceuticals
o Theratechnologies
o Mylan Pharmaceuticals
o Genentech
o AbbVie
Increasing Prevalence of AIDS will Create Growth Opportunities
The rising prevalence of HIV/AIDS has resulted in increasing emphasis on the development of treatment methods and drugs associated with the treatment of this disease. According to data published by the Joint United Nations Program in 2018, around 37.9 million people in the world are diagnosed with HIV/AIDS. Among the 37.9 million people, around 23.3 million people were undergoing antiretroviral therapy.
Due to the increasing incidence of HIV/AIDS across the world, the HIV/AIDS drugs companies have witnessed massive growth opportunities in recent years. The large patient pool will offer a huge potential for growth of several companies in the market, which in turn, will have a direct impact on the global HIV/AIDS drugs market in the forthcoming years. The report includes several factors that constituted an increase in the global HIV/AIDS market value in recent years.
Fortune Business Insights has profiled a few of the prominent companies that have contributed to the growth of the global HIV/AIDS drugs market in recent years. Besides, Fortune Business Insights identifies some of the key strategies adopted by a few of these companies.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hiv-aids-drugs-market-101115
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Epidemiology of HIV/AIDS by Key Countries
4.2. Overview of Pipeline Analysis
4.3. Regulatory Scenario by Key Countries
4.4. Pricing Analysis
4.5. Key Strategies Employed by Market Leaders in Various Regions
4.6. Overview of New Product Launches
5. Global HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Drug Class
5.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
5.2.2. Integrase Inhibitors
5.2.3. Combination HIV Medicines
5.2.4. Others
5.3. Market Analysis, Insights and Forecast - By Distribution Channel
5.3.1. Hospital Pharmacies
5.3.2. Retail Pharmacies
5.3.3. Online Pharmacies
5.3.4. Others
5.4. Market Analysis, Insights and Forecast - By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Rest of World
6. North America HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis - By Drug Class
6.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
6.2.2. Integrase Inhibitors
6.2.3. Combination HIV Medicines
6.2.4. Others
6.3. Market Analysis - By Distribution Channel
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.3.4. Others
6.4. Market Analysis - By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis - By Drug Class
7.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
7.2.2. Integrase Inhibitors
7.2.3. Combination HIV Medicines
7.2.4. Others
7.3. Market Analysis - By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.3.4. Others
7.4. Market Analysis - By Country/ Sub-Region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis - By Drug Class
8.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
8.2.2. Integrase Inhibitors
8.2.3. Combination HIV Medicines
8.2.4. Others
8.3. Market Analysis - By Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.3.4. Others
8.4. Market Analysis - By Country/ Sub-Region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
Continued...
KEY QUESTIONS ANSWERED:
o What are the key technological and Hiv Drugs Market trends shaping the market?
o What are the key opportunities in the market?
o What are the key companies operating in the market?
o Which company accounted for the highest market share?
o Why Choose Fortune Business Insights?
o What is the market size and growth rate of the global and regional market by various segments?
o What is the market size and growth rate of the market for selective countries?
o Which region or sub-segment is expected to drive the market in the forecast period?
o What Factors are estimated to drive and restrain the Hiv Drugs Market growth?
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release How Hiv Drugs Market Will Dominate In Coming Years? Key Players: ViiV Healthcare, Gilead Sciences, Merck Sharp & Dohme, Bristol-Myers Squibb Company, Janssen, Pharmaceuticals, Theratechnologies, Mylan Pharmaceuticals, Genentech, AbbVie, others here
News-ID: 2023804 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd.
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period.
Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called…
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive.
Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent…
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027.
List of…
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…